Insmed
INSM
INSM
100 hedge funds and large institutions have $998M invested in Insmed in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 14 closing their positions.
Holders
100
Holders Change
-1
Holders Change %
-0.99%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
32
Reduced
31
Closed
14
Calls
$5.44M
Puts
$22.9M
Net Calls
-$17.5M
Net Calls Change
-$19.6M
Top Buyers
| 1 |
1
BlackRock
New York
|
$82M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$6.72M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$189M |
| 4 |
JGC
4
J. Goldman & Co
New York
|
$3.87M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$66.2M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$84.2M |
| 2 |
EA
2
Emerald Advisers
Leola,
Pennsylvania
|
$18.3M |
| 3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3.47M |
| 4 |
4
Citigroup
New York
|
$365K |
| 5 |
NC
5
Nexthera Capital
New York
|
$0 |
